1. Home
  2. BDTX vs BGH Comparison

BDTX vs BGH Comparison

Compare BDTX & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • BGH
  • Stock Information
  • Founded
  • BDTX 2014
  • BGH 2012
  • Country
  • BDTX United States
  • BGH United States
  • Employees
  • BDTX N/A
  • BGH N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • BGH Investment Managers
  • Sector
  • BDTX Health Care
  • BGH Finance
  • Exchange
  • BDTX Nasdaq
  • BGH Nasdaq
  • Market Cap
  • BDTX 292.0M
  • BGH 289.9M
  • IPO Year
  • BDTX 2020
  • BGH N/A
  • Fundamental
  • Price
  • BDTX $5.65
  • BGH $15.17
  • Analyst Decision
  • BDTX Strong Buy
  • BGH
  • Analyst Count
  • BDTX 3
  • BGH 0
  • Target Price
  • BDTX $13.00
  • BGH N/A
  • AVG Volume (30 Days)
  • BDTX 864.0K
  • BGH 61.5K
  • Earning Date
  • BDTX 08-09-2024
  • BGH 01-01-0001
  • Dividend Yield
  • BDTX N/A
  • BGH 10.06%
  • EPS Growth
  • BDTX N/A
  • BGH N/A
  • EPS
  • BDTX N/A
  • BGH N/A
  • Revenue
  • BDTX N/A
  • BGH N/A
  • Revenue This Year
  • BDTX N/A
  • BGH N/A
  • Revenue Next Year
  • BDTX N/A
  • BGH N/A
  • P/E Ratio
  • BDTX N/A
  • BGH N/A
  • Revenue Growth
  • BDTX N/A
  • BGH N/A
  • 52 Week Low
  • BDTX $1.62
  • BGH $11.92
  • 52 Week High
  • BDTX $7.66
  • BGH $14.50
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 61.49
  • BGH 79.84
  • Support Level
  • BDTX $4.28
  • BGH $14.30
  • Resistance Level
  • BDTX $4.75
  • BGH $14.77
  • Average True Range (ATR)
  • BDTX 0.38
  • BGH 0.12
  • MACD
  • BDTX 0.11
  • BGH 0.06
  • Stochastic Oscillator
  • BDTX 93.17
  • BGH 88.76

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests

Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.

Share on Social Networks: